Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 266-840-7 | CAS number: 67656-24-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 6 July 2017 - 3 Nov 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- Version / remarks:
- 04 February 2015
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Landesamt für Umwelt, Wasserwirtschaft und Gewerbeaufsicht
- Type of study:
- direct peptide reactivity assay (DPRA)
Test material
- Reference substance name:
- Sodium 2-butoxyethyl sulphate
- EC Number:
- 266-840-7
- EC Name:
- Sodium 2-butoxyethyl sulphate
- Cas Number:
- 67656-24-0
- Molecular formula:
- C6H14O5S.Na
- IUPAC Name:
- sodium 2-butoxyethyl sulphate
- Test material form:
- solid
Constituent 1
In chemico test system
- Details on the study design:
- The test substance was dissolved in deionized water. Three samples of the test substance were incubated with each peptide (i.e., cysteine peptide or lysine peptide). Additionally, triplicates of the concurrent vehicle control were incubated with the peptides. These vehicle controls were prepared as three separates sets, set A, set B, and set C. Set A was analyzed together with the calibration samples without incubation and served as a performance control. Sets B and C were prepared and
incubated with the samples. Set B was placed at the very start and ending of the sample list and served as stability control of the peptide over the analysis time. Set C was analyzed with the samples and served for calculation of the peptide depletion of any chemical formulated in the vehicle.
Positive and co-elution controls also were evaluated. The positive control used was ethylene dim ethacrylate (50 mM) and the co-elution control was peptide buffer with the test substance but without peptide. The remaining non-depleted peptide concentration was determined thereafter by HPLC with gradient elution and UV-detection at 220 nm.
For the assay to be considered valid, the following criteria needed to be met:
The standard calibration curve was an r² > 0.99.
The negative control (vehicle control) samples of sets A and C were 0.50 mM +/- 0.05 mM.
The CV of the nine vehicle controls B and C were < 15%.
The variability between the mean of three single samples was low (SD < 14.9% for % cysteine de
pletion and < 11.6% for % lysine depletion).
The positive control caused depletion of both peptides comparable to historic data.
For results to be considered negative, the mean peptide depletion is ≤ 6.38%. All other results are considered positive with low (> 6.38 ≤ 22.62%), moderate (> 22.62 ≤ 42.47%), or high (> 42.47%) reactivity. In the case where mean peptide depletion could be determined, but valid C-peptide depletion was available, a C peptide depletion of ≤ 13.89% was considered negative. All other results are considered positive with low (> 13.89 ≤ 23.09), moderate (> 23.09 ≤ 98.24), or high (> 98.24) reactivity.
Results and discussion
- Positive control results:
- The positive control caused depletion of both peptides comparable to historic data.
In vitro / in chemico
Resultsopen allclose all
- Parameter:
- other: mean cysteine peptide depletion
- Value:
- 5.02
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Parameter:
- other: mean lysine peptide depletion
- Value:
- -0.53
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Parameter:
- other: mean of both peptide depletions
- Value:
- 2.51
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: The test substance was dissolved in de-ionized water at a concentration of 100 mM. The samples of the test substance with the peptides were solutions at the time of preparation. Visual observation after the 24-hour incubation time did not reveal precipitates in any samples of the test substance with the peptides.
DEMONSTRATION OF TECHNICAL PROFICIENCY: The mean peptide concentration of the three samples of set A was 0.505 ± 0.005 mM, demonstrating good performance. The mean peptide concentration of the three samples of set B, analyzed at the beginning of the sample list was calculated to be 0.485 ± 0.008 mM. The other three samples of set B, analyzed at the end of the sample list had a mean peptide concentration of 0.471 ± 0.014 mM. The CV of the 9 vehicle control samples of sets B and C was calculated to be 2.2%. Thus the peptide was considered stable over the time of analysis.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes
- Acceptance criteria met for positive control: yes
- Acceptance criteria met for variability between replicate measurements: yes
Applicant's summary and conclusion
- Interpretation of results:
- other: no skin sensitising potential based on the key event “protein reactivity”
- Conclusions:
- Based on the observed results and applying the cysteine 1:10 / lysine 1:50 prediction model, it was concluded that Sodium 2-butoxyethyl sulphate shows minimal or no chemical reactivity in the DPRA under the test conditions chosen.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
